title: It is not time to stop progesterone receptor testing in breast cancer.
authors.forename: R
authors.initials: R
authors.lastname: Colomer
authors.forename: M
authors.initials: M
authors.lastname: Beltran
authors.forename: J
authors.initials: J
authors.lastname: Dorcas
authors.forename: H
authors.initials: H
authors.lastname: Cortes-Funes
authors.forename: J
authors.initials: J
authors.lastname: Hornedo
authors.forename: V
authors.initials: V
authors.lastname: Valentin
authors.forename: C
authors.initials: C
authors.lastname: Vargas
authors.forename: C
authors.initials: C
authors.lastname: Mendiola
authors.forename: E
authors.initials: E
authors.lastname: Ciruelos
mesh_terms: D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000628:therapy*; D003657:Decision Making; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging / Q000191:economics / Q000379:methods*; D010347:Patient Care Planning; D011237:Predictive Value of Tests; D011379:Prognosis; D011980:Receptors, Progesterone / Q000032:analysis*
chemical_list: D011980:Receptors, Progesterone